TRAVEL NURSING NEWS
A collection of nursing news for the ultimate travel nurse!

Article Date: 10/16/2009

Vaccine Demonstrates Robust Immune Response After One Dose
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that a single dose of influenza A (H1N1) 2009 monovalent vaccines, Panenza (15 mcg dose, non-adjuvanted) or Humenza (3.8 mcg dose, adjuvanted), administered to children (3 years of age or older) and adults induces a robust immune response, according to results from clinical trials in Europe. The results found that one dose induced a robust antibody response that is considered protective in 93 percent or more of adults 18 to 59 years old and 83 percent or more of adults 60 years of age or older. In children 3 years of age through 17 years of age, 94 percent or more of study participants achieved seroprotective antibody response. Both vaccines tested met the three European Medicines Agency's (EMEA) criteria.

Website Address: http://www.sanofi-aventis.us

MORE NURSING NEWS ARTICLES

TRAVEL NURSING NEWS
Read all the news you want here at Travel Nursing News!
Travel Nursing news gives you one source to find all the nursing news on-line.